Entering text into the input field will update the search result below

Aadi Bioscience GAAP EPS of -$0.68, revenue of $4.24M

Nov. 09, 2022 8:12 AM ETAadi Bioscience, Inc. (AADI) StockBy: Deepa Sarvaiya, SA News Editor
  • Aadi Bioscience press release (NASDAQ:AADI): Q3 GAAP EPS of -$0.68.
  • Revenue of $4.24M.
  • Cash, cash equivalents and short-term investments as of September 30, 2022 were $183.0 million as compared to $149.0 million as of December 31, 2021, which is expected to fund operations into 2025 based on current plans.

Recommended For You

More Trending News

About AADI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AADI--
Aadi Bioscience, Inc.